CollPlant Biotechnologies Ltd
Rehovot, Center District, Israel · Biotechnology, Healthcare, Manufacturing
CollPlant is a regenerative and aesthetic medicine company ushering in a new era of medical solutions with a focus on 3D bioprinting of tissues and organs, tissue repair and medical aesthetics. The Company's products are based on its rhCollagen (recombinant human collagen) produced with proprietary plant-based genetic engineering technology. These products address indications for the diverse field
Key facts
- Headquarters
- Rehovot, Center District, Israel
- Employees
- 61
- Industries
- Biotechnology, Healthcare, Manufacturing
- Status
- Public (OPHI)
- Website
- collplant.com
- Company page
Recent activity at CollPlant Biotechnologies Ltd
- : CollPlant Biotechnologies Ltd (date of first sale on the SEC Form D)
- : CollPlant Biotechnologies announces a $3.7 million private placement led by existing investors to accelerate LightSolver's laser-based supercomputing development.
- : CollPlant to acquire LightSolver for tech expansion
- : CollPlant Biotechnologies announces $2.6 million private placement to enhance working capital and research efforts, with H.C. Wainwright & Co. as placement agent.
- : CollPlant has launched BioFlex, a ready-to-print rhCollagen-based kit for 3D bioprinting applications.
- : CollPlant Biotechnologies Appoints Bowman Bagley as Vice President, Commercial North America
- : CollPlant and Stratasys Initiate Pre-clinical Study for Regenerative Commercial-Sized Breast Implants (date Fundz recorded it)
- : CollPlant Biotechnologies Ltd
- : CollPlant Biotechnologies Ltd
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
CollPlant Biotechnologies Ltd funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2026 | Venture | $9.2M |
| Oct 2026 | Post-IPO Equity | $3.7M |
| Jun 2026 | Post-IPO Equity | $2.6M |
| Mar 2020 | Seed | $4.5M |
| Sep 2019 | Seed | $3.5M |
Leadership
- Eran Rotem, Deputy CEO & Chief Financial Officer
- Joseph Zarzewsky, Director
- Gili Hart, Director
- Elan Penn, Director
- Abraham Havron, Director
- Roger Pomerantz, Director
- Scott Burrell, Director
- Wolfgang Ruttenstorfer, Director
Verified email and direct lines for CollPlant Biotechnologies Ltd’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
CollPlant Biotechnologies Ltd in the news
- COLLPLANT IS ACQUIRING LIGHTSOLVER- ENTERS SUPERCOMPUTING AND PHOTONIC COMPUTING MARKETS - PR Newswire (Aug 31, 2026)
- When Will CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Turn A Profit? - Yahoo Finance (Feb 08, 2026)
- COLLPLANT COMPLETES ACQUISITION OF LIGHTSOLVER, ENTERING THE PHOTONIC COMPUTING SECTOR - PR Newswire (Sep 03, 2026)
- CollPlant Biotechnologies (Nasdaq:OPHI) - Stock Analysis - Simply Wall St (Nov 13, 2026)
- CollPlant Biotechnologies Ltd. (CLGN) Stock Price, News, Quote & History - Yahoo! Finance Canada (Apr 10, 2018)
- CollPlant to Host LightSolver Investor Webinar on September 17, 2026 - PR Newswire (Sep 10, 2026)
- COLLPLANT ANNOUNCES REVERSE SHARE SPLIT - PR Newswire (Sep 01, 2026)
- LightSolver, a CollPlant Company, and HLRS Joint Research Demonstrated Photonic Computing Can significantly Accelerate Fundamental HPC Workloads - PR Newswire (Sep 24, 2026)
Companies similar to CollPlant Biotechnologies Ltd
- Cognito Therapeutics · Biotechnology, Healthcare, Manufacturing
- Precision Optics Corporation · Biotechnology, Healthcare, Manufacturing
- Omniscient Neurotechnology · Biotechnology, Healthcare, Manufacturing
- Ionetix Corp · Biotechnology, Healthcare, Manufacturing
- Shape Memory Medical · Biotechnology, Healthcare, Manufacturing
About CollPlant Biotechnologies Ltd: questions and answers
What does CollPlant Biotechnologies Ltd do?
CollPlant is a regenerative and aesthetic medicine company ushering in a new era of medical solutions with a focus on 3D bioprinting of tissues and organs, tissue repair and medical aesthetics. The Company's products are based on its rhCollagen (recombinant human collagen) produced with proprietary plant-based genetic engineering technology. These products address indications for the diverse field
Where is CollPlant Biotechnologies Ltd headquartered?
CollPlant Biotechnologies Ltd is headquartered in Rehovot, Center District, Israel.
How many employees does CollPlant Biotechnologies Ltd have?
CollPlant Biotechnologies Ltd has about 61 employees.
Has CollPlant Biotechnologies Ltd raised funding?
Yes. Fundz has recorded 5 funding events for CollPlant Biotechnologies Ltd. The most recent, $9.2M, was in Oct 2026.
Who leads CollPlant Biotechnologies Ltd?
Eran Rotem is a Deputy CEO & Chief Financial Officer at CollPlant Biotechnologies Ltd.
What is the latest news on CollPlant Biotechnologies Ltd?
On Oct 9, 2026, CollPlant Biotechnologies Ltd
Is CollPlant Biotechnologies Ltd a public company?
Yes. CollPlant Biotechnologies Ltd is publicly traded under the ticker OPHI.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy